Table 1. Estimated population with neovascular age-related macular degeneration (AMD), 2008–2011, Brazil.
Year | Age | Population a | Population, AMD b | Population, neovascular AMD c |
---|---|---|---|---|
2008 | 70–79 | 5,834,495 | 126,609 | 268,228 |
≥ 80 | 2,669,251 | 275,734 | ||
2009 | 70–79 | 6,009,549 | 130,407 | 279,292 |
≥ 80 | 2,793,135 | 288,531 | ||
2010 | 70–79 | 6,305,085 | 136,820 | 293,378 |
≥ 80 | 2,935,585 | 303,246 | ||
2011 | 70–79 | 6,350,417 | 137,804 | 295,451 |
≥ 80 | 2,956,176 | 305,373 |
apopulation projected,
bmeta-analysis was conducted using random effects,
c neovascular AMD would account for two-thirds of all cases of the disease.